Target intelligence / Profile preview

Peptidoglycan D-alanyl-D-alanine terminus and pentaglycine cross-link (D-Ala-D-Ala/Pentaglycine)

Target
D-Ala-D-Ala/Pentaglycine
Molecular classification
Bacterial cell wall component, Other
01

Overview

Peptidoglycan is an essential polymer that forms a mesh-like layer outside the plasma membrane of most bacteria, providing structural strength and protection against osmotic lysis (PubMed, PMID: 18476318). The D-alanyl-D-alanine (D-Ala-D-Ala) terminus is a critical structural motif found on the peptide stems of peptidoglycan precursors, such as Lipid II, and nascent peptidoglycan chains in Gram-positive bacteria (StatPearls, NBK459358). Glycopeptide antibiotics, including vancomycin and teicoplanin, target this motif by forming hydrogen bonds with the D-Ala-D-Ala dipeptide, which sterically inhibits the transpeptidation and transglycosylation steps of cell wall synthesis (PubMed, PMID: 11084357). The pentaglycine bridge is a specific interpeptide cross-link, most notably found in Staphylococcus aureus, that connects the L-lysine of one peptide stem to the D-alanine of another (PubMed, PMID: 1489457). This bridge is the primary target for the bacteriolytic enzyme lysostaphin, which cleaves the glycine-glycine bonds within the bridge to cause rapid cell wall degradation (PubMed, PMID: 15105404). Because these structures are unique to bacteria and absent in human cells, they represent highly selective targets for antimicrobial therapy. However, the emergence of resistance, such as the modification of D-Ala-D-Ala to D-Ala-D-Lac, poses a significant challenge to the continued efficacy of drugs targeting these sites (PubMed, PMID: 10601204). These targets are primarily relevant in the treatment of severe infections caused by Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE).

Other names
D-Ala-D-Ala terminusPentaglycine bridgePeptidoglycan cross-bridgeLipid II D-Ala-D-Ala
02

Mechanism of action

Glycopeptide antibiotics bind to the D-Ala-D-Ala terminus to inhibit transpeptidation and transglycosylation, while enzymes like lysostaphin cleave the pentaglycine bridge to cause bacterial lysis.

03

Biological functions

Cell wall synthesisStructural integrityOsmotic protectionOther
04

Disease associations

Infection
05

Safety considerations

NephrotoxicityOtotoxicityRed man syndromeDevelopment of antibiotic resistance (VRE/VRSA)
06

Interacting drugs

Vancomycin

5 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)Vancomycin-resistant Enterococci (VRE) screeningVancomycin-resistant Staphylococcus aureus (VRSA) screening

Beyond the preview

Go deeper on Peptidoglycan D-alanyl-D-alanine terminus and pentaglycine cross-link (D-Ala-D-Ala/Pentaglycine).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidoglycan D-alanyl-D-alanine terminus and pentaglycine cross-link (D-Ala-D-Ala/Pentaglycine).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call